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Abstract
Objective  and Aim: The objective of the following study is to examine the effectiveness and safety of suspension 
laryngoscopy under intubation with propofol and remifentanil alone for vocal fold nodule (VFN) excision.
Materials and Methods: A total of 40 patients were equally and randomly assigned to elective VFN excision using 
suspension laryngoscopy under intubation with propofol and remifentanil alone (Group A) or with supplementary 
cisatracurium (Group B).
Results: Intubation time was significantly longer in Group A than in Group B (300.0 ± 30.0 s vs. 265.2 ± 38.7 s, 
P = 0.003). The two groups showed similar Cormack‑Lehane classifications, intubation conditions and ease of 
suspension laryngoscopy. Both groups showed favorable cardiopulmonary safety profiles. Post‑anesthesia recovery 
was significantly more rapid in Group A than in Group B, in terms of times to spontaneous breathing return (7.2 ± 1.4 min 
vs. 10.9 ± 1.6 min, P < 0.001), consciousness return (7.4 ± 1.5 min vs. 12.3 ± 1.8 min, P < 0.001), removal of tracheal 
intubation (8.1 ± 1.5 min vs. 13.2 ± 1.7 min, P < 0.001) and operating room discharge (12.7 ± 1.4 min vs. 22.1 ± 1.3 min, 
P < 0.001).
Conclusion: Use of propofol and remifentanil alone provides favorable intubation and anesthesia conditions for 
suspension laryngoscopic VFN excision and accelerates post‑anesthesia recovery.
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Introduction
Vocal fold nodule (VFN) is a common laryngological 
condition that mainly occurs secondary to chronic abusive 
voice practice and inflammation.[1] The most frequently 
reported chief complaint is hoarseness of speech, which 
rarely harms the patient’s general well‑being but impairs 
his/her activities of daily life, especially for professionals 
depending on voice and speech.[2] The basic treatment 
for VFN consists of vocal training, speech therapy and, 
more importantly, vocal rest. Medical intervention is 
required in some cases, but the therapeutic effect is 
believed to be limited. In contrast, VFN excision, a minor 
laryngological procedure, achieves a definitive treatment 
outcome.[3] Multiple laryngoscopic techniques, including 
direct, indirect, electronic and fiber‑optic laryngoscopies, 
have been used for VFN excision in current practice.[3] The 
selection of a specific laryngoscopic technique depends 
mainly on the location and pathology of the disease.[3]
Suspension laryngoscopy is a laryngological technique that 
enables clear visualization of the laryngeal anatomy and 
precise excision of vocal fold lesions, especially refractory 
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or recurrent VFNs.[4] The incorporation of laser ablation 
in suspension laryngoscopy preserves the normal vocal fold 
mucosae and minimizes the risk of VFN recurrence.[5] A 
review of the current literature regarding the laryngoscopic 
treatment of VFNs showed that suspension laryngoscopy 
is more effective and has a better safety profile than other 
laryngoscopic techniques.[6]
Suspension laryngoscopy is inevitably subject to some 
technical problems, especially with respect to anesthesia 
management.[7] VFN excision using suspension laryngoscopy 
is highly irritative, but can be completed within a short 
period of time.[7] This short operative time requires rapid 
induction, maintenance and recovery of anesthesia, a 
challenge that anesthesiologists resolve by using superficial 
anesthesia or, more frequently, general anesthesia with 
rapid induction and intubation, which normally requires 
muscle relaxant supplementation.[8] However, the use 
of neuromuscular blockers (NMBs) is risky in patients 
undergoing suspension laryngoscopy due to the limited time 
period available for anesthesia management. Recovery from 
muscle relaxation also prolongs anesthesia and operating 
turnover times.
Intubation without muscle relaxation (IWMR) has been 
developed in current adult and pediatric practice.[9] The 
administration of a combined regimen of propofol, a 
short‑acting intravenous hypnotic agent and remifentanil, 
a potent ultra‑short‑acting synthetic opioid analgesic, 
has been recommended for patients scheduled for brief 
operations under IWMR.[10] This combined anesthetic 
modality offers a favorable condition for intubation and 
laryngoscopic procedures.[10,11] Recent studies have also 
shown that the combined modality is associated with a better 
cardiopulmonary safety profile than the administration 
of propofol or remifentanil alone.[10,11] However, a 
knowledge gap exists in the current literature regarding 
the safety and effectiveness of IWMR for VFN excision 
using suspension laryngoscopy. We thus investigated the 
anesthetic effectiveness and safety of IWMR in patients 
with VFNs undergoing suspension laryngoscopic excision 
in a patient‑blinded, randomized, controlled study.
Materials and Methods
Patient enrollment and assignment
This study protocol was approved by the institutional 
review board at the First Hospital of Jilin University and was 
performed in accordance with the Declaration of Helsinki. 
Patients with VFNs were prospectively and consecutively 
enrolled at the First Hospital of Jilin University between 
July 2010 and January 2011. All subjects provided voluntary 
written informed consent prior to enrollment. The inclusion 
criteria were: Age 18‑65 years, body mass index (BMI) of 
18.5‑25 kg/m2, Class I or II physical status according to the 
American Society of Anesthesiologists (ASA), Mallampati 
class (a measure predicting the ease of intubation) I or 
II,[12] and scheduling for elective suspension laryngoscopic 
excision under IWMR. The exclusion criteria were: 
A medical history of myopathy; a known history of allergy to 
propofol and/or remifentanil or drug abuse; and/or a previous 
history of upper respiratory tract infection within 3 weeks of 
enrollment, gastrointestinal reflux, intracranial pathology, 
suspected difficult airway, or serious cardiopulmonary or 
hepatorenal insufficiency.
A computer‑generated random number table was used 
to randomly and equally assign subjects to IWMR with 
propofol/remifentanil alone (Group A) or tracheal 
intubation with propofol/remifentanil and additional 
cisatracurium (Group B). All operations were performed 
by an assigned team of head and neck surgeons assisted by 
resident surgeons, anesthesiologists, surgical nurses, clinical 
pathologists and research nurses. Patients were blinded to 
the treatment assignment throughout the study.
Anesthetic technique
All patients were premedicated with 0.5 mg intramuscular 
atropine sulfate (Harvest Pharmaceutical Co., Ltd, 
Shanghai, China) 30 min prior to the operation. Intravenous 
access was established and an automated non‑invasive 
monitoring system (Philips Medical Systems, Herrsching, 
Germany) equipped with an electrocardiograph, automatic 
cuff inflation/deflation sphygmomanometer and pulse 
oximeter was used to continuously measure the patient’s 
heart rate (HR), mean arterial pressure (MAP) and 
blood oxygen saturation (SpO2). Midazolam (0.03 mg/kg; 
Nhwa Pharmaceutical Co., Ltd., Xuzhou, China) was 
administered for the induction of anesthesia, followed 
by a target‑controlled infusion (TCI) of 3.0 µg/mL 
propofol (AstraZeneca UK Limited, London, UK) and 
5.0 ng/mL remifentanil hydrochloride (Humanwell 
Pharmaceutical Co., Ltd., Yichang, China) using a TCI 
syringe pump system (SLGO Medical Technology Co., Ltd., 
Beijing, China). Patients in Group A were medicated with 
normal saline as placebo (Kelun Pharmaceutical Co., Ltd., 
Chengdu, China) and those in Group B with 0.1 mg/kg 
cisatracurium besilate (Hengrui Pharmaceutical Co., Ltd., 
Lianyungang, China), in accordance with the treatment 
assignment. Prior to intubation, patients received superficial 
anesthesia with 10 mg/mL tetracaine (Jiuxu Pharmaceutical 
Co., Ltd., Jinhua, China). An independent anesthetist 
performed tracheal intubation within 5 min of superficial 
anesthesia for patients in Group A or at the time of the 
first twitch response (T1) maximum depression rate <5% 
for patients in Group B. An automatic neuromuscular 
conductivity monitor (Axon Systems Ltd., Inning, 
Germany) was used to determine the level of muscle 
relaxation. The TCI of propofol and remifentanil was 
adjusted according to HR and MAP monitoring during 
Zhuang, et al.: Suspension laryngoscopy with IWMR
458 Nigerian Journal of Clinical Practice • Jul-Aug 2014 • Vol 17 • Issue 4
suspension laryngoscopy, whereas intravenous remifentanil 
was uptitrated by 1 ng/mL, but no more than 2 ng/mL. 
Supplementary 1 × ED95 cisatracurium besilate was given 
if the T1 maximum depression rate was>10%.
Post‑anesthesia management
Following VFN excision, the intravenous medication 
was withdrawn immediately in patients in Group A. For 
patients in Group B, intravenous propofol and remifentanil 
were downtitrated to 2 µg/mL and 2 ng/mL, respectively; 
the intravenous medication was withdrawn and residual 
muscle relaxants were antagonized using intravenous 
neostigmine (Ange Pharmaceutical Co. Ltd, Huai’an, 
China) when the train‑of‑four (TOF) response manifested 
as one or two twitches. Tracheal intubation was removed 
when the patient exhibited normal swallowing and coughing 
reflexes, voluntary eye opening in response to vocal 
stimulation, tidal volume >5 mL/kg and a respiratory rate 
of 10‑20 breaths/min. The patient was discharged from 
the operating room (OR) when he or she showed normal 
vital signs and respiration and coughing reflexes, remained 
alert and oriented and maintained an SpO2 >94% while 
breathing air for 3 min consecutively. In addition, patients 
in Group B were required to have a TOF ratio >0.9, which 
was depressed following TOF peripheral nerve stimulation.
Outcome measures
The primary outcome measures were post‑anesthesia 
recovery times, including the times from induction to 
spontaneous breathing return, consciousness return, 
removal of tracheal intubation and OR discharge. The 
secondary outcome measures included HR and MAP 
prior to (T0) and following (T1) induction, as well as at 
the times of intubation (T2), laryngoscope insertion (T3) 
and withdrawal (T4), tracheal extubation (T5) and OR 
discharge (T6). Other secondary measures included intubation 
time from induction to the completion of intubation; 
operative time; Cormack‑Lehane classification,[13] which 
describes the laryngeal view on laryngoscopy; and overall 
intubation condition assessment,[14] number of intubation 
attempts, ease of suspension laryngoscopy[15] and Observer’s 
Assessment of Alertness/Sedation (OAA/S) Scale[16] scores 
at T5 and T6.
Statistical analysis
The SPSS 13.0 software package (SPSS Inc., Chicago, 
IL, USA) was used for statistical analysis. All continuous 
data are expressed as means ± standard deviations and 
differences in means were analyzed using Student’s t‑test for 
two independent samples or one‑way analysis of variance 
for multiple independent samples. All categorical data 
are expressed as n (%) and intergroup differences were 
examined using Fisher’s exact probability test. For two‑tailed 
tests, a P value was considered to be statistically significant 
if <0.05.
Results
A total of 40 patients with VFNs, consisting of 17 males and 
23 females, were included in this study and equally assigned 
to the two treatment arms. The patients’ demographic data 
are shown in Table 1. The two groups were comparable 
in terms of age, sex, height, weight, BMI and ASA 
classification (P > 0.05).
Intubation conditions are shown in Table 2. Laryngoscope 
introduction and endotracheal intubation were completed 
successfully completed in a single attempt in all patients. 
Visualization of the vocal cord was determined to be very 
satisfactory and satisfactory in 80% (32/40) and 20% (8/40) 
of patients, respectively. Intubation time was significantly 
longer in Group A than in Group B (300.0 ± 30.0 s vs. 
265.2 ± 38.7 s, P = 0.003), whereas overall operative 
Table 1: Demographic data of patients (n=40) 
scheduled for elective suspension laryngoscopic 
excision of vocal fold nodules





Age, years 43.3±6.7 45.2±7.4 0.399
Sex, M/F 11/9 6/14 0.200
Height, cm 166.6±5.6 164.0±6.2 0.177
Weight, kg 64.6±7.9 63.8±9.5 0.759
Body mass index, kg/m2 23.3±3.1 23.7±2.8 0.739
ASA classification, n (%)
Class I 12 (60.0) 10 (50.0) 0.751
Class II 8 (40.0) 10 (50.0)
Group A=Patients undergoing intubation with propofol/remifentanil 
but without muscle relaxants, Group B=Patients undergoing intubation 
with propofol/remifentanil and additional cisatracurium, ASA=American 
Society of Anesthesiologists
Table 2: Intubation conditions and ease of suspension 






Intubation time, s 300.0±30.0 265.2±38.7 0.003
Operative time, min 7.2±2.5 6.8±7.2 0.589
Cormack-Lehane 
classification, n (%)
Class 1 15 (75.0) 16 (80.0) 0.705
Class 2 5 (25.0) 4 (20.0)
Overall intubation 
condition, n (%)
Excellent 17 (85.0) 20 (100.0) 0.072
Good 3 (15.0) 0 (0.0)
Ease of suspension 
laryngoscopy, n (%)
Very satisfactory 16 (80.0) 17 (85.0) 0.677
Satisfactory 4 (20.0) 3 (15.0)
Group A=Patients undergoing intubation with propofol/remifentanil but 
without muscle relaxants, Group B=Patients undergoing intubation with 
propofol/remifentanil and additional cisatracurium
Zhuang, et al.: Suspension laryngoscopy with IWMR
459Nigerian Journal of Clinical Practice • Jul-Aug 2014 • Vol 17 • Issue 4
time (interval between laryngoscope introduction and 
completion of suspension laryngoscopy) was comparable 
between groups (7.2 ± 2.5 min vs. 6.8 ± 7.2 min, 
P = 0.589). Groups A and B also exhibited similar 
Cormack‑Lehane classifications (Class 1, 75.0% vs. 80.0%; 
Class 2, 25.0% vs. 20.0%; P = 0.705). Intubation conditions 
were excellent in nearly all patients, except in 3 patients 
in Group A with good intubation conditions (excellent, 
85.0% vs. 100.0%; good, 15.0% vs. 0.0%; P = 0.072). In 
addition, surgeon‑assessed ease of suspension laryngoscopy 
was comparable between groups (very satisfactory, 80.0% 
vs. 85.0%; satisfactory, 20.0% vs. 15.0%; P = 0.677). No 
laryngeal spasm occurred in any patient.
Peri‑anesthesia hemodynamic changes are plotted in Figure 1. 
No significant difference in HR was found between groups at 
any timepoint (P > 0.05). Moreover, the two groups showed 
comparable MAPs at all timepoints (all P > 0.05), except 
at the time of extubation (T5), when MAP was significantly 
lower in Group A than in Group B (94.7 ± 3.8 mmHg vs. 
99.6 ± 9.0 mmHg, P = 0.031). In Group A, HRs were 
stable compared with baseline (T0) values at all timepoints, 
except for a significantly lower HR at T1 (67.5 ± 6.4 bpm 
vs. 76.2 ± 5.8 bpm, P < 0.001); however, MAPs were 
significantly lower than baseline at most timepoints 
following induction (T1–T4, T6; all P < 0.05), except at 
T5 (94.7 ± 3.8 mmHg vs. 96.1 ± 8.3 mmHg, P = 0.497). 
Group B showed similar intragroup changes in HR 
and MAP: HRs were significantly lower at T1 than at 
T2 (69.8 ± 10.5 bpm vs. 77.9 ± 7.5 bpm, P = 0.008), MAPs 
were significantly lower than baseline at T1–T4 and T6 (all 
P < 0.05) and HR and MAP remained relatively stable at 
all other timepoints (all P > 0.05). Changes in HR and 
MAP from baseline values were <20% in both groups and 
were determined to be clinically insignificant. No episode 
of muscle rigidity, bradycardia, or hypotension requiring 
specific medical intervention was reported during the study. 
SpO2 values remained normal (95‑100%) during anesthesia 
and suspension laryngoscopy in all patients, regardless of 
treatment assignment.
Post‑anesthesia recovery times are shown in Table 3. 
Post‑anesthesia recovery was significantly more rapid in 
Group A than in Group B in terms of times to spontaneous 
breathing return (7.2 ± 1.4 min vs. 10.9 ± 1.6 min, 
P < 0.001), consciousness return (7.4 ± 1.5 min vs. 
12.3 ± 1.8 min, P < 0.001), removal of tracheal 
intubation (8.1 ± 1.5 min vs. 13.2 ± 1.7 min, P < 0.001) 
and OR discharge (12.7 ± 1.4 min vs. 22.1 ± 1.3 min, 
P < 0.001). However, OAA/S scores were comparable 
between groups at T5 (4.4 ± 0.8 vs. 4.5 ± 0.8, P = 0.836) 
and T6 (4.8 ± 0.4 vs. 4.8 ± 0.4, P = 0.714).
Discussion
Suspension laryngoscopy normally offers an excellent view of 
the laryngeal anatomy, but requires delicate peri‑anesthesia 
management in current practice.[7] Non‑depolarizing NMBs 
are used adjunctively in general anesthesia to facilitate 
endotracheal intubation and to maintain skeletal muscle 
relaxation in laryngeal intervention. The most serious safety 
concerns regarding the use of NMBs in endotracheal intubation 
and general anesthesia for suspension laryngoscopy are delayed 
breathing recovery and respiratory impairment following 
extubation due to residual NMBs.[17] The TOF response is 
commonly used for NMB monitoring, which requires the use 
of a delicate NMB monitoring system.[18] Recovery from NMBs 
prolongs the anesthesia time and increases medical cost, 
especially for a minor laryngeal operation such as suspension 
Table 3: Post‑anesthesia recovery times and OAA/S 
scores (mean±SD) of patients (n=40) undergoing 







Spontaneous breathing return 7.2±1.4 10.9±1.6 <0.001
Consciousness return 7.4±1.5 12.3±1.8 <0.001
Extubation 8.1±1.5 13.2±1.7 <0.001
Operating room discharge 12.7±1.4 22.1±1.3 <0.001
OAA/S score at
Extubation 4.4±0.8 4.5±0.8 0.836
Operating room discharge 4.8±0.4 4.8±0.4 0.714
OAA/S=Observer’s assessment of alertness/sedation scale, SD=Standard 
deviation
Figure 1: Changes in heart rate (a) and mean arterial pressure (b) in patients with vocal fold nodules undergoing suspension laryngoscopy 
without (Group A) and with (Group B) muscle relaxants. Timepoints are prior to (T0) and following (T1) anesthesia induction and at the 
times of intubation (T2), laryngoscope insertion (T3) and withdrawal (T4), tracheal extubation (T5) and operating room discharge (T6)
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laryngoscopy. Thus, the proper use of NMBs plays a critical 
role in the effectiveness and safety of VFN excision using 
suspension laryngoscopy. Multiple modified IWMR regimens 
have been proposed for laryngoscopic surgery.[10,11] Our 
primary study finding was that endotracheal intubation with 
propofol and remifentanil alone yielded favorable anesthesia 
and surgical outcomes, comparable with those achieved with 
NMB supplementation, in patients undergoing suspension 
laryngoscopic VFN excision. In addition, this anesthetic 
technique significantly shortened the post‑anesthesia recovery 
time.
The use of NMBs is believed to reduce the time required 
for endotracheal intubation, but the difference is only 35 s 
and is not clinically significant. Moreover, the number and 
success rate of intubation attempts are similar between 
patients undergoing IWMR and those receiving NMBs. The 
absence of NMBs does not impair the endoscopic view of the 
laryngeal structures, clear visualization of which is essential 
for definitive and safe VFN excision using suspension 
laryngoscopy. Precise excision also minimizes the risks of 
iatrogenic injury and disease recurrence. The intubation 
condition is known to be closely associated with the 
depth of anesthesia at the time of intubation.[19] Although 
the intubation conditions are excellent in a smaller 
percentage of patients undergoing IWMR with propofol 
and remifentanil alone, this situation does not increase the 
difficulty of intubation in terms of the clinical outcome. 
From the point of view of otorhinolaryngologists, IWMR 
with propofol and remifentanil alone also facilitates the 
performance of suspension laryngoscopy. Patients remain 
well sedated and the vocal folds remain static, although 
suspension laryngoscopy without the use of NMBs can 
be stressful. Choking occurs frequently during IWMR,[20] 
but this adverse event can be prevented by administering 
superficial tetracaine prior to the procedure. Only four of our 
patients experienced mild choking during IWMR, probably 
due to an incomplete superficial blockade, whereas no limb 
or vocal fold movement was observed.
The primary safety concerns in the use of a combined regimen 
of propofol and remifentanil are sympathetic nervous system 
hypotonia, respiratory depression and muscle rigidity.[21] 
However, our hemodynamic data demonstrate that IWMR 
with propofol and remifentanil alone provided favorable 
hemodynamic stability, similar to that achieved with NMB 
supplementation. The risk of adverse effects depends primarily 
on the dose and infusion rate of propofol and remifentanil.[22] 
We used optimal doses of 3.0 µg/mL propofol and 5.0 ng/mL 
remifentanil by TCI in this study, as recommended by previous 
reports for adult patients.[23] This combined anesthetic 
modality maintained an adequate depth of anesthesia, with 
hemodynamic changes remaining within 20% of baseline 
values following intubation with and without NMBs. However, 
the absence of NMBs in patients undergoing IWMR can 
maximize the safety of the combined propofol and remifentanil 
modality because NMBs such as cisatracurium can multiply 
the adverse effects of the two drugs, such as hypotension, 
respiratory depression and histamine release, although these 
effects have been rarely reported.[22]
The most striking benefit of IWMR compared with 
intubation with NMBs for patients undergoing suspension 
laryngoscopic excision is the significant acceleration of 
post‑anesthesia recovery, due primarily to rapid muscle tone 
recovery. This favorable effect further shortens the times 
required for consciousness return, tracheal extubation and 
OR discharge. No muscle relaxant antagonist administration 
is required in patients undergoing IWMR. This technique 
is expected to reduce patients’ physical and psychological 
stress, as well as medical costs related to general anesthesia 
with intubation.
We acknowledge that this study had some limitations. Firstly, 
the sample size was relatively small; the study included only 
40 patients with VFNs who were scheduled for suspension 
laryngoscopic excision. Secondly, the investigators were 
not blinded to the treatment assignment, as required by 
the institutional protocol due to safety concerns regarding 
NMB use; thus, the study data were likely confounded by 
the investigators’ bias. Thirdly, we were unable to stratify 
our patients according to the complexity of VFN excision 
due to the small sample size. As the great majority of our 
patients did not have complex vocal fold disease, it remains 
unknown whether IWMR with propofol and remifentanil 
alone can be attempted in patients with VFNs requiring 
longer intubation due to complex laryngeal conditions. 
Fourthly, the eligibility criteria for intubation, extubation 
and OR discharge were mainly based on predefined TOF 
ratio cutoffs, whereas the TOF ratio is known to be highly 
variable among individuals and not always accurately 
predictive of NMB residual.
Conclusion
The combined regimen of propofol and remifentanil provides 
favorable intubation and anesthesia conditions for subsequent 
suspension laryngoscopic VFN excision, similar to the modality 
with NMB supplementation. The two anesthetic techniques 
exhibited good cardiopulmonary safety profiles, but IWMR 
with propofol and remifentanil alone significantly shortened 
post‑anesthesia recovery times from induction to extubation 
and OR discharge. Large‑scale, double‑blind, randomized, 
controlled trials are required to further validate the benefits 
of IWMR with propofol and remifentanil alone in patients 
with VFNs undergoing suspension laryngoscopic excision.
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